Abstract
Scant data are available concerning the impact and response to therapy of respiratory syncytial virus (RSV) infections in patients undergoing autologous blood and marrow transplantation (BMT) for breast cancer. During eight winter seasons from 1992–1993 to 1999–2000, nine (4%) of 249 such patients were hospitalized with RSV infections. Six patients, including all five patients who were early post transplant in the pre-engraftment period, developed pneumonia and were treated with a combination of aerosolized ribavirin and IVIG. Among five patients with pneumonia in whom therapy was initiated prior to respiratory failure, one (20%) died. The sixth patient, in whom therapy was initiated after respiratory failure developed, also died. In total, two (1%) patients, both of whom were in the pre-engraftment period, died of progressive pneumonia. In conclusion, RSV is a significant cause of life-threatening pneumonia in autologous BMT recipients with breast cancer during the early post-transplant period, and accounted for a substantial portion of the overall transplant-related mortality, which in recent years has been minimal. Bone Marrow Transplantation (2001) 28, 271–275.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Englund JA, Sullivan CJ, Jordan C et al. Respiratory syncytial virus infections in immunocompromised adults Ann Intern Med 1988 109: 203–208
Ljungman P, Gleaves CA, Meyers JD . Respiratory virus infections in immunocompromised patients Bone Marrow Transplant 1989 4: 35–40
Hertz MI, Englund JA, Snover D et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature Medicine 1989 68: 269–281
Whimbey E, Bodey GP . Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses Semin Respir Infect 1992 7: 122–131
Harrington RD, Hooton RD, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center J Infect Dis 1992 165: 987–993
Whimbey E, Champlin R, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplants Bone Marrow Transplant 1995 16: 393–399
Whimbey E, Couch R, Englund J et al. Respiratory syncytial virus pneumonia among hospitalized adult patients with leukemia Clin Infect Dis 1995 21: 376–379
Whimbey E, Champlin R, Couch R et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients Clin Infect Dis 1996 22: 778–782
DeVincenzo JP, Leombruno D, Soiffer RJ, Siber GR . Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation Bone Marrow Transplant 1996 17: 1051–1056
Whimbey E, Englund JA, Couch RB . Community respiratory virus infections in immunocompromised patients with cancer Am J Med 1997 102: 10–18
Bowden RA . Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center Experience Am J Med 1997 102: 27–30
Llungman P . Respiratory virus infections in bone marrow transplant recipients: the European perspective Am J Med 1997 102: 44–47
Sparrelid E, Ljungman P, Ekelof-Andstrom E et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections Bone Marrow Transplant 1997 19: 905–908
Boeckh M, Bowden RA, Berry MM et al. Phase I evaluation of a RSV-specific humanized monoclonal antibody (MEDI-493) after hematopoietic stem cell transplantation (HSCT). In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California 1998 (Abstr. MN-20)
McColl MD, Corser RB, Bremner J, Chopra R . Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin Bone Marrow Transplant 1998 21: 423–425
McCarthy AJ, Kingman HM, Kelly GS et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation Bone Marrow Transplant 1999 15: 1315–1322
DeVincenzo JP, Hirsch RL, Fuentes RJ, Top Jr FH . Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience Bone Marrow Transplant 2000 25: 161–165
Whimbey E, Ghosh S . Respiratory syncytial virus infections in immunocompromised adults. In: Remington JS, Swartz MN (eds) Current Clinical Topics in Infectious Diseases Blackwell Science: Malden, MA 2000 pp 232–255
Ghosh S, Champlin RE, Englund J et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin Bone Marrow Transplant 2000 25: 751–755
Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer New Engl J Med 2000 342: 1069–1076
Hortobagyi GN, Buzdar AU, Theriault RL et al. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast cancer J Natl Cancer Inst 2000 92: 225–233
Glezen WP, Denny FW . Epidemiology of acute lower respiratory diseases in children New Engl J Med 1973 288: 498–505
Hall CB, McBride JT, Walsh EE et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection: a randomized double-blind study New Engl J Med 1983 308: 1443–1447
Prince GA, Hemming VG, Horswood RL, Chanock RM . Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat Virus Res 1985 3: 193–206
Hemming VG, Prince GA, Horswood RL et al. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model J Infect Dis 1985 152: 1083–1087
Gruber WC, Wilson SZ, Throop BJ, Wyde PR . Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat Pediatr Res 1987 21: 270–274
Hemming VG, Rodriguez W, Kim HW et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children Antimicrobial Agents Chemother 1987 31: 1882–1886
Siber GR, Leszcynski J, Pena-Cruz V et al. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay J Infect Dis 1992 165: 456–463
Groothuis JR, Simoes EAF, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children New Engl J Med 1993 329: 1524–1530
Graham BS, Davis TH, Tang YW, Gruber WC . Immunoprophylaxis and immunotherapy of respiratory syncytial virus infected mice with respiratory syncytial virus specific immune serum Pediatr Res 1993 34: 167–172
Ottolini MG, Prince GA, Darnell MR et al. Immunoprophylaxis and immunotherapy are effective against respiratory syncytial virus infection in immunocompromised cotton rats Pediatr Res 1993 33: 178A
Connor E, Group TPS . Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis Pediatrics 1997 99: 93–99
The Impact-RSV study group . Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 1998 102: 531–537
Malley R, De Vincenzo J, Ramilo O et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein J Infect Dis 1998 178: 1555–1561
Ottolini MG, Porter DD, Hemming VG et al. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model Bone Marrow Transplant 1999 24: 41–45
Englund JA, Whimbey E, Atmar RL . Diagnosis of respiratory viruses in cancer and transplant patients In: Remington JS, Swartz MN (eds) Current Clinical Topics in Infectious Diseases Blackwell Science: Malden, MA 1999 pp 30–59
Raad I, Abbas J, Whimbey E . Infection control of nosocomial respiratory viral disease in the immunocompromised host Am J Med 1997 102: 48–52
Garcia R, Raad I, Abi-Said D et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients Infect Control Hosp Epidemiol 1997 18: 412–416
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghosh, S., Champlin, R., Ueno, N. et al. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant 28, 271–275 (2001). https://doi.org/10.1038/sj.bmt.1703131
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703131
Keywords
This article is cited by
-
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
Bone Marrow Transplantation (2013)
-
An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment
Bone Marrow Transplantation (2003)